SU = sulfonylurea a Ontario prices presented Source: Sponsors pharmacoeconomic submission 1 Results of the sponsors base case suggested an incremental cost of $3,355,258 in Year 1, $10,231,784 in Year 2, and $21,706,463 in Year 3, for a total incremental cost of $35,293,505 over the 3-year time horizon, when oral semaglutide is reimbursed as an adjunct to diet and exercise to improve glycemic control in adults with T2DM as monotherapy when metformin is considered inappropriate due to intolerance or contraindications or in combination with other medicinal products
Because weight loss is central to every management guideline, but very hard to achieve and maintain, the rise of GLP-1 RAs, which consistently help with weight loss and may also directly lower intracranial pressure, raised the question of whether they could contribute to treatment
But the sudden silence can also reveal the stress, emotions, and problems the food noise was masking
Then Thanksgiving rolls around, and suddenly you're staring down a week of family dinners, multiple desserts, and your uncle's famous c